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Abstract In this study the reliability and validity of
generic and disease-speciﬁc questionnaires has been as-
sessed focusing on responsiveness. This is part of a study
on the effects of recurrent acute otitis media (rAOM) on
functional health status (FHS) and health-related quality of
life (HRQoL) in 383 children with rAOM participating in a
randomized clinical trial. The following generic question-
naires were studied: 1. RAND general health rating index,
2. Functional Status Questionnaire (FSQ Generic and FSQ
Speciﬁc), 3. TNO-AZL Infant Quality of Life (TAIQOL),
and the following disease-speciﬁc questionnaires: 1. Otitis
Media-6 (OM-6), 2. Numerical rating scales (NRS) for
child and caregiver (NRS Child and NRS Caregiver), and
3. a new Family Functioning Questionnaire (FFQ). Reli-
ability was good to excellent (Cronbach’s a range 0.80–
0.90, intraclass correlation coefﬁcient range 0.76–0.93).
Moderate to strong correlations were found between the
questionnaires as well as between questionnaires and rel-
evant clinical indicators (r = 0.29–0.49), demonstrating
construct validity. Discriminant validity for children with
few versus frequent episodes of acute otitis media per year
was good for most questionnaires (P < 0.004) but poor for
the otitis media-related subscales of the TAIQOL (P =0 . 1 0 –
0.97) and both NRS (P = 0.22 and 0.48). Except for the
TAIQOL subscales, change scores were signiﬁcant
(P < 0.003) for generic and disease-speciﬁc questionnaires.
Effect sizes were somewhat higher for disease-speciﬁc
compared to generic questionnaires (0.55–0.95 versus 0.32–
0.60) except for the TAIQOL subscales, which showed very
poor sensitivity to change. Anchor-based methods resulted in
a somewhat larger range of estimates of MCID than distri-
bution-based methods. Combining distribution-based and
anchor-based methods resulted in similar ranges for the
minimally clinical important differences for generic and
disease-speciﬁc questionnaires: 2–15 points on a 0–100
scale. Apart from the generic TAIQOL subscales, both
generic and disease-speciﬁc questionnaires used in this study
showed good psychometric qualities and responsiveness for
use in clinical studies on children with rAOM.
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Introduction
Acute otitis media (AOM) is a common childhood infection
with a peak incidence occurring between 6 and 12 months
of age. Five to ﬁfteen percent of all children, depending on
their age, suffer from recurrent acute infections of the
middle ear (4 or more episodes per year) [1–4]. Repetitive
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DOI 10.1007/s11136-007-9242-0episodes of pain, fever and general illness during acute ear
infections [5–8] as well as worries about potential long-term
sequelae such as hearing loss and disturbed language
development [9–13] may all compromise the quality of life
of the child and its family [14–16]. Although several
questionnaires have been used in assessing the effects of
recurrent acute otitis media (rAOM) in children, lack of true
health-related quality of life (HRQoL) questionnaires as
well as incomplete data on their reliability and validity
mean that our current knowledge on the subject is limited
for both research and clinical practice [17].
Assessment of functional health status (FHS) and
HRQoL, as deﬁned in Table 1 [18–26], has become
increasingly important in clinical trials on the effectiveness
of treatment in paediatric chronic conditions. The valida-
tion of FHS and HRQoL questionnaires, however, has so
far mainly focused on reliability and construct validity.
Responsiveness has been assessed for only a few paediatric
HRQoL questionnaires for conditions other than otitis
media [27–31]. In order to evaluate treatment effects on
FHS and HRQoL meaningfully, questionnaires are needed
that are not only reliable and valid but also responsive to
changes in FHS and HRQoL. In adult studies, various
strategies have been used to assess responsiveness, which
is deﬁned as the ability to detect clinically important
change over time and therefore involves both the assess-
ment of sensitivity to change and the assignment of
meaning to that change [32, 33]. Since none of these
strategies is without limitations, we will try to assess the
responsiveness of FHS and HRQoL questionnaires by
using multiple strategies, categorized into distribution-
based and anchor-based methods.
Distribution-based methods express the amount of
change relative to the amount of random variance of a
questionnaire [34, 35], whereas anchor-based methods
enhance interpretability of changes in questionnaire scores
by linking meaning and clinical relevance to change scores
[34, 36].
Both generic and disease-speciﬁc questionnaires have
been used in studies of paediatric FHS or HRQoL. Generic
questionnaires span a wide spectrum of quality of life
components, bridging various health states and populations.
Disease-speciﬁc questionnaires on the other hand, assess
health-related issues speciﬁc to particular conditions and
may be able to detect small changes that are often small but
clinically important; these provide a more detailed
assessment of HRQoL, but cannot be used for comparisons
across health conditions [37–39]. Both questionnaires are
often combined in order to proﬁt from the merits of both
types. However, there have been few head-to-head com-
parisons between generic and disease-speciﬁc HRQoL
measurement questionnaires in the setting of randomized
controlled trials (RCT) [40].
The current RCT on the effectiveness of pneumococcal
vaccination in children with rAOM will address both the
issues of using generic versus disease-speciﬁc question-
naires and responsiveness in evaluating treatment effects
on HRQoL in RCTs. The results will lead to recommen-
dations regarding the applicability of these questionnaires
in clinical studies in children with rAOM.
Methods
Setting and procedure
FHS and HRQoL were assessed in 383 children with
rAOM participating in a double-blind randomized, pla-
cebo-controlled trial on the effectiveness of pneumococcal
conjugate vaccination versus control hepatitis vaccination.
The study was conducted at the paediatric outpatient
departments of a general hospital (Spaarne Hospital
Haarlem) and a tertiary care hospital (University Medical
Center Utrecht). Children were recruited for this trial
through referral by general practitioners, paediatricians, or
otolaryngologists, or were enrolled on the caregiver’s own
initiative from April 1998 to February 2001.
Study population
Inclusion criteria: children were aged between 12 and
84 months and suffering from rAOM at study entry; de-
ﬁned in this study as having had at least 2 episodes of
physician diagnosed AOM in the year prior to study entry.
Exclusion criteria were conditions with a known increased
risk for AOM such as: known immunodeﬁciency (other
than IgA or IgG2 subclass deﬁciency), cystic ﬁbrosis,
immotile cilia syndrome, cleft palate, chromosomal
abnormalities (like Down syndrome) or severe adverse
events upon vaccination in the past.
At each scheduled visit, two research physicians
(C.N.M.B. and R.H.V.) collected data regarding the
Table 1 Deﬁnitions of health-related quality of life and functional health status
Health-related quality of life: Level of satisfaction a person inputes to those aspects of his or her life that are affected by the effects of illness
and its treatment [18–20]. Incorporation of a person’s valuation of his life distinguishes HRQoL from other
measures of well-being [21, 22].
Functional health status: Reﬂection of the (severity of) signs and symptoms and the adequacy of daily functioning across various life-
domains in an individual with a certain health condition [23–26].
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123number of episodes of AOM (based on parental report at
baseline and on physician report during follow-up), upper
respiratory tract infections, and pneumonia. Information
about the medical treatment, and ear, nose, and throat
surgery in the preceding 6 months was also collected. The
primary caregivers completed questionnaires assessing
FHS and HRQoL of their child and family during the clinic
visits at baseline and at 7, 14, and 26 months follow-up.
Caregivers were requested to have the same person com-
plete the questionnaires each time and to rate their child’s
FHS and HRQoL with regard to their recurrent episodes of
acute otitis media. Informed consent was obtained from
caregivers of all children before study entry. Medical ethics
committees of both participating hospitals approved the
study protocol.
Questionnaires
Four generic questionnaires (RAND, FSQ Generic, FSQ
Speciﬁc, TAIQOL) and one disease-speciﬁc questionnaire
(OM-6) were used to assess FHS and HRQoL of the
children in the study. Additionally, two disease-speciﬁc
one-item numerical rating scales (NRS Child and NRS
Caregiver) were used to obtain a global rating of HRQoL
of the child and of the caregiver, respectively, related to
rAOM. For the assessment of the impact of rAOM on
family functioning a newly composed disease-speciﬁc
questionnaire the Family Functioning Questionnaire
(FFQ), was used to assess the impact of rAOM on family
functioning. Table 2 summarises the characteristics of the
questionnaires [14, 41–57].
Generic questionnaires
The RAND general health-rating index (RAND) and the
Functional Status Questionnaire (FSQ) had already been
translated and validated for Dutch children by Post et al.
[41, 42] (Table 2). The RAND assesses general health
perceptions of caregivers regarding their child [43]. The
FSQ consists of two parts: one measuring functional lim-
itations in general, not necessarily related to illness (FSQ
Generic) and the other (paradoxically named FSQ Speciﬁc)
measuring functional limitations that are attributable to any
illness [43]. Functional limitations in both versions of the
FSQ are mainly expressed as behavioural problems. During
the course of the study, a new Dutch questionnaire on
generic HRQoL became available: the TNO-AZL Infant
Quality of Life (TAIQOL) questionnaire [51, 53]. For this
reason, from July 1999 the TAIQOL was added to the
previously selected set of questionnaires. Although the full,
original version of the TAIQOL has been applied during
the study, only those subscales from the TAIQOL are
discussed that, based on their content, were assumed to be
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123sensitive to the consequences of AOM. The following
subscales tap functional items that are often affected by
AOM (OM-related): ‘Sleeping’, ‘Appetite’, ‘Liveliness’,
‘Problem behaviour’, ‘Positive mood’, and ‘Communica-
tion’ (items about speech and language capacity) which are
6 of the 12 subscales in the TAIQOL. Although the TAI-
QOL has been developed for children aged up to 5 years,
we also used the questionnaire in children aged 6–7 years,
as no appropriate alternative was available during the
study.
Disease-speciﬁc questionnaires
To measure disease-speciﬁc FHS, the Otitis Media-6 (OM-
6) [14, 55] was translated into Dutch according to principles
of backward–forward translation [58–61]. This six-item
questionnaire covers both acute and long-term functional
effects of otitis media in children on FHS.
A new questionnaire has been developed to assess the
impact of rAOM in children on their caregivers and sib-
lings: the FFQ. The content of the FFQ was based on
previous work by Asmussen et al. [15, 62] on the impact of
rAOM on family well-being. A panel of paediatric otorh-
inolaryngologists and paediatricians from our study sites
selected the items most relevant according to their clinical
experience. The FFQ is composed of six questions cover-
ing effects of the child’s rAOM on caregiver and family
activities and two questions assessing these effects on
emotional behaviour of the other siblings. The Likert-scale
was used as a response format and was analogous to that of
the RAND and OM-6 in our study, ranging from score 1–4.
Furthermore, two numerical rating scales (NRS) (0–100)
were used, the NRS Child and the NRS Caregiver (see
Table 2). The NRS Child [14] was translated into Dutch
using the same principles of backward–forward translation
that have been applied to translation of the OM-6. The
newly created NRS Caregiver was modelled upon the NRS
Child and added to the previously selected set of ques-
tionnaires from July 1999. The NRS caregiver has been
created in this study, following the example of the NRS
child which was created by Rosenfeld et al. [14].
Finally, the Dutch version of the OM Functional Status
Questionnaire speciﬁc (OMFSQ [52]) was included as an
anchor for responsiveness (instrument description in sec-
tion on responsiveness).
Questionnaire application
Questionnaires were completed in a randomly selected, but
ﬁxed order during the follow-up assessments to prevent
possible inﬂuence of order effects [63, 64]: RAND, FSQ
Generic and Speciﬁc, OM-6, NRS Child, FFQ, TAIQOL,
OMFSQ, NRS Caregiver. For all questionnaires higher
scores indicate the presence of a better HRQoL or FHS. To
allow comparisons between scores on the questionnaires,
all scores were linearly transformed into 0–100 Scales. For
each questionnaire, the evaluation period was the 6 weeks
before completion.
Statistical analyses
Floor and ceiling effects
Floor and ceiling effects were estimated for the baseline-
assessment of each questionnaire by calculating percent-
ages of respondents that had minimum and maximum
scores, respectively. Questionnaires should exhibit minimal
ﬂoor and ceiling effects to be optimally able to detect
difference and change.
Reliability
First, internal consistency was assessed by calculating
Cronbach’s alpha, which should be above 0.70 for each
questionnaire or subscale [65]. Inter-item correlations of
questionnaires were assessed to reveal item redundancy or
‘hidden’ subscales that may erroneously yield a high
overall Cronbach’s alpha.
For the assessment of test–retest reliability, a subset of
caregivers attending the outpatient ward from February
2000 to June 2001 (n = 160) was given a second set of the
same questionnaires (retest) to complete at home. The time
frame for completion was 2 weeks after the ﬁrst set of
questionnaires was ﬁlled out during the outpatient visit at
14 months (ﬁrst test). Children with AOM at the ﬁrst test
were excluded, since differences in their scores could be
due to real change and interfere with the assessment of
reliability.
For the assessment of test–retest reliability, a time-
interval of 2–14 days is often considered long enough to
preventrecall bias and too short forrelevant change to occur
in chronic disease [66]. Test–retest reliability was computed
as the intraclass correlation coefﬁcients (ICC) between the
two sets of questionnaires. An ICC of 0.80 was considered
the required minimum for good reliability [65, 67].
Construct and discriminant validity
In order to demonstrate construct validity, hypotheses were
formulated about the strength of correlations between
questionnaires. A higher percentage of correct predictions
indicates stronger support for construct validity. A corre-
lation of 0.10–0.30 was deﬁned as weak, 0.30–0.50 as
moderate, and >0.50 as strong [68]. The correlation
between FSQ Generic and NRS Caregiver was predicted
1360 Qual Life Res (2007) 16:1357–1373
123to be weak since they were expected to assess two different
constructs. Moderate to strong correlations (r > 0.40) were
predicted between RAND and NRS Caregiver. Moderate to
strong correlations were also expected between OM-6 and
FSQ Speciﬁc, NRS Child, NRS Caregiver and FFQ, as all
assess otitis media-related HRQoL or FHS. The correlation
between FSQ Generic and FSQ Speciﬁc was expected to be
strong (r > 0.50). The remaining correlations among the
questionnaires were expected to be moderate (Table 5).
Additionally, correlations between questionnaire scores
and frequency of physician visits for upper respiratory tract
infections as well as frequency of AOM episodes in the
preceding 6 months were calculated. Since distributions of
questionnaire scores were skewed, correlations were as-
sessed using Spearman’s rho.
Discriminant validity was assessed by dichotomizing the
study participants in children with 2–3 versus 4 or more
episodes of otitis media per year. Based on clinical and
immunological data, children with 4 or more AOM epi-
sodes per year are considered as ‘otitis prone’ [2, 69–71],
reﬂecting a sub-group with an increased rate of upper
respiratory tract infections, related medical interventions
and compromised child functioning [72, 73]. It was as-
sumed that this group would perform signiﬁcantly poorer
than children with 2–3 otitis media episodes per year on all
questionnaires, which was assessed by independent sample
Mann–Whitney tests.
Responsiveness
Since pneumococcal conjugate vaccination showed no
clinical effectiveness when compared to the control vac-
cine [74], the intervention could not be used as an external
criterion of change. Data of both vaccine groups were
pooled instead for the assessment of responsiveness to
spontaneous remission. The clinical experience of a panel
of 5 experts in the ﬁeld of otitis media, formed the basis for
deﬁning a reduction of 2 or more episodes of AOM per
child per year as the external criterion for change while a
reduction of 1 episode or less identiﬁed no change.
Responsiveness was evaluated for two intervals: from 0 to
7 months and from 7 to 14 months follow-up. The ob-
served change in these episodes was multiplied by 12/7
(1,714) to get the estimated change per year.
The ﬁrst step in the assessment of responsiveness was to
explore the ability of questionnaires to detect change at all,
i.e., its sensitivity to change. Secondly,meaningandclinical
relevanceofthechangescoreweredeterminedinaccordance
with recent recommendations, using both distribution- and
anchor-based methods [36, 75–77]. Distribution-based
methodsexpresstheamountofchangerelativetotheamount
of random variance of a questionnaire [34, 35]. Some ratios
of change to random variance have, often empirically, been
foundtorepresentaminimallyclinicalimportantdifference.
Anchor-based methods enhance interpretability of changes
in questionnaire scores by linking meaningful and clinically
relevant indicators to change scores [34, 36].
The assessment of responsiveness will be described in
further detail below.
Sensitivity to change
Sensitivity to change was assessed by calculating both the
statistical signiﬁcance of change scores using a paired t-test
or Wilcoxon matched pairs test (for skewed distributions),
and effect sizes (ES) using Guyatt’s responsiveness statistic
[78] for changed subjects. In this statistic, the observed
change that occurred in changed subjects is related to the
observed random change or random error, in unchanged
subjects. A parametric effect size was computed as: mean
change score changed group/SD (change score unchanged
group); a nonparametric effect size was computed as:
median change score changed group/interquartile range
(change score unchanged group)).
According to the benchmarks of Cohen [79], an effect
size of 0.2 represents a small change, 0.5 a moderate
change and 0.8 or higher represents a large change. For
skewed distributions Wilcoxon matched pairs test was used
to calculate the signiﬁcance of change.
Clinical relevance of change scores
The interpretation of change is often assessed by calcu-
lating the minimally clinical important difference (MCID),
which is the smallest difference in a questionnaire total or
domain score that patients perceive as beneﬁcial [80]. The
MCID can be computed from both distribution-based and
anchor-based methods. Several estimates of the MCID
from both methods are reported, to assess the likely range
of the MCID for each questionnaire.
Interpretation of change—distribution-based methods (ES-
MCID and SEM-MCID)
The main distribution-based methods for assessing the
MCID are the Effect Size and the Standard Error of
Measurement. A change in questionnaire scores corre-
sponding to the effect size of Guyatt’s Responsiveness
Statistic with values of 0.3–0.5 has been found to be con-
sistent with other (empirical) estimates of the MCID [36,
81–83]. In this study the change in questionnaire scores
corresponding with an effect size of 0.3 is used as
benchmark of MCID (ES-MCID). A change of one Stan-
dard Error of Measurement (1-SEM) has empirically been
found to correspond with the MCID of a questionnaire [77,
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12384–86]. The 1-SEM of a questionnaire links reliability of
an instrument to the variance of scores in a population as
reﬂected in its formula: 1-SEM = SD (change scores un-
changed subjects) *  (1-ICC). It is an estimate of what part
of the observed change may be due to random measure-
ment error by including distribution of scores (SD) and
instrument reliability (ICC). Change larger than the SEM
therefore is considered ‘real’ change. The SEM is here used
as an estimate of the MCID (SEM-MCID). The ES-MCID
and SEM-MCID support the interpretation of measured
change, as they reﬂect the smallest change that is sub-
stantially larger than the random variability in the study
population which is based on the standard deviation of the
unchanged subjects.
Interpretation of change—anchor-based methods
Anchor-based methods require an independent standard,
the anchor, that in itself is easily interpretable and that is at
least moderately correlated (>0.3) with the questionnaire
being assessed. Changes in questionnaire scores were
compared with change in two clinically relevant anchors:
the AOM frequency (incidence of AOM episodes per child)
and the AOM severity assessed with the Dutch version of
the OM-Functional Status Questionnaire speciﬁc (OM-
FSQ) [52]. The OM-FSQ was used as an anchor for
responsiveness. It consists of three questions assessing
clinical AOM severity: earache, sleeping problems, and
other signs and symptoms (irritability, fussiness, fever) that
may indicate the presence of an ear infection. In our pop-
ulation, the OM-FSQ demonstrated high internal consis-
tency (Cronbach’s a = 0.88) and good test–retest reliability
(ICC = 0.94). The OM-FSQ correlated weakly with the
NRS Child (Spearman’s rho = 0.18), but moderately with
the RAND (0.36), FSQ Generic (0.37), and NRS Caregiver
(0.34), and strongly with the FSQ Speciﬁc (0.52), OM-6
(0.73) and FFQ (0.61).
In relation to the AOM frequency, an expert panel in the
ﬁeld of otitis media considered a reduction of 2 episodes
per year as a small or minimal clinically important change,
whereas a change of 3 to 4 episodes per year was consid-
ered moderate to large. In the study of Alsarraf et al. [52],
the OM-FSQ total score was about 62 on a scale of 0–100
during an episode of AOM, increasing to 92 at 6 weeks and
to 90 at 12 weeks after an episode of AOM with higher
scores reﬂecting less severe ear-related symptoms. There-
fore, a score change of 10–20 on the 0–100 scale of the
OM-FSQ in the current population was considered to be a
small clinically relevant change in AOM severity, a score
change of 30–50 as moderate to large. Anchor-based esti-
mates of the MCID were computed as the change in
questionnaire scores associated with small changes in
AOM frequency and OM-FSQ.
For all analyses the Statistical Package for the Social
Sciences (SPSS) version 10.1 was used.
Results
Population
The population characteristics summarized in Table 3 show
that the majority of children suffered from 4 or more AOM
episodes per year, and half of them suffered from chronic
airway problems or atopic symptoms. Most children had
undergone one or more ENT surgeries. Overall they seemed
to suffer from more severe disease than the average child
with 2–3 middle ear infections, as stated earlier.
Floor and ceiling effects
Generally, the questionnaires demonstrated no ﬂoor-ef-
fects. However, Table 4 shows that some questionnaires
(FSQ Speciﬁc and FFQ) and most TAIQOL subscales
showed moderate to large ceiling effects, which indicates
that measurement of improvement may be limited while it
may actually be present.
Table 3 Characteristics of study population*
Mean or %
(n = 383)
SD or 95%
CI
Age (months) 34 (19.7)
Male gender 62% (57–67)
In the year prior to inclusion
Number of AOM episodes/year 5.0 (2.7)
2–3 37% (32–42)
4–5 31% (26–36)
6 or more 32% (27–37)
Impaired hearing** 35% (30–40)
Language or speech problems** 22% (18–26)
History of
Chronic airway problems or atopic
symptoms ***
51% (46–56)
Adenoidectomy 47% (42–52)
Tympanostomy tubes 51% (46–56)
Other ear-, nose-, and throat surgeries 2% (0.6–3)
Antibiotic prophylaxis 15% (11–19)
Ever had speech-therapy 9% (6–12)
* at inclusion in the study
** reported by the caregiver
*** asthma, wheezing, hayfever, or eczema
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Cronbach alpha coefﬁcients were adequate to high (range
0.72–0.90) for the TAIQOL subscales and high (range
0.80–0.90) for all other questionnaires. The calculation of
inter-item correlations revealed no ‘hidden’ subscales or
item redundancy (i.e., individual correlations are too high,
with possible loss of content validity) (Table 4).
In order to assess test–retest reliability, 126 (79%) of
160 approached caregivers completed a second set of
questionnaires of which 113 (71%) were completed within
2 weeks. Seven children with AOM at the time of the
outpatient visit (test 1) were excluded, resulting in 106 sets
for analysis (Table 4). ICCs were moderate to high for all
questionnaires (range 0.81–0.93) and most TAIQOL sub-
scales (range 0.76–0.90), but in the borderline range for the
TAIQOL subscale ‘Liveliness’ (0.76).
Construct and discriminant validity
Table 5 reﬂects the calculated correlations between the
questionnaires, which ranged from moderate to strong for
the RAND, FSQ Generic, FSQ Speciﬁc, OM-6, and FFQ.
These outcomes show that 14 (67%) of the hypothesized
correlations were correct. False predictions were mainly
made about the NRS Child and NRS Caregiver, as the
correlations with other questionnaires were generally
expected to be at least moderate, but were found to be
weak. Disease-speciﬁc questionnaires (OM-6, NRS Child,
FFQ and NRS Caregiver), showed moderate correlations
(Spearmans’ rho 0.39–0.49) with the frequency of AOM
episodes in the preceding 6 months. Moderate correlations
(Spearmans’ rho 0.29–0.48) were also found between
global FHS (RAND) and the disease-speciﬁc question-
naires on the one hand and the number of physician visits
Table 4 Floor and ceiling
effects*, internal consistency
and test–retest reliability of the
questionnaires
* percentage of respondents
with minimum (ﬂoor effect) and
maximum (ceiling effect) scores
** n = 169 for the TAIQOL
subscales and NRS Caregiver
*** Intra-class Correlation
Coefﬁcient
Minimum
score (%)
Maximum
score (%)
Internal consistency
Cronbach’s a
n=383**
Test–retest
reliability ICC***
n=106
Generic
RAND 0 0 0.81 0.89
FSQ generic 0 2 0.80 0.92
FSQ speciﬁc 0 21 0.86 0.89
TAIQOL N.A. N.A. 0.72–0.90 0.76–0.90
Sleeping 2 12 0.90 0.83
Appetite 0 22 0.86 0.82
Positive mood 0 80 0.90 0.81
Liveliness 0.6 81 0.88 0.76
Problem behaviour 1 4 0.86 0.85
Communication 0.4 53 0.88 0.82
Disease-speciﬁc
OM-6 0 14 0.85 0.89
NRS child 2 3 N.A. 0.83
FFQ 0.5 27 0.90 0.93
NRS caregiver 0 0 N.A. 0.81
Table 5 Construct validity: calculated correlations * between the questionnaires**
RAND FSQ generic FSQ speciﬁc OM-6 NRS child FFQ NRS caregiver
RAND 1.00 0.52 0.49 0.34 0.33 0.43 0.49
FSQ generic 1.00 0.80 0.37 0.25 0.43 0.24
FSQ speciﬁc 1.00 0.49 0.26 0.52 0.24
OM-6 1.00 0.23 0.74 0.28
NRS child 1.00 0.22 0.47
FFQ 1.00 0.39
NRS caregiver 1.00
* Spearman correlation coefﬁcients were calculated
** appropriately a ` priori predicted correlations are bold-printed
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global indicator of illness, on the other hand (Table 6).
The RAND, FSQ Generic, FSQ Speciﬁc, OM-6 and
FFQ were able to discriminate between children with
moderately recurrent AOM (2–3 episodes per year) and
‘‘otitis-prone’’ children with severe, recurrent AOM (4 or
more episodes per year) (Table 7). However, neither the
two numerical rating scales (NRS Child and NRS Care-
giver) nor the otitis media-related subscales of the TAI-
QOL discriminated between these two groups.
Responsiveness
Accordingto ourexternal criterion of change (a reduction of
2ormoreepisodesofAOMperyear),270children(70%)of
383 were classiﬁed as ‘changed’ for the ﬁrst interval (0–
7 months)and126children(33%)forthesecondinterval(7–
14 months). The two intervals differed considerably
regarding the reduction of AOM incidence; during the 0–
7 months follow-up the mean incidence per child decreased
by 1.8 AOM episodes, whereas during 7–14 months follow-
up the mean decrease was 0.35 episodes [74].
Sensitivity to change
Sensitivity to change, expressed as signiﬁcant mean change
and effect size, is presented in Table 8. Except for most
TAIQOL subscales, generic as well as disease-speciﬁc
questionnaires yielded signiﬁcant change scores during
both follow-up periods, ranging from 4.9 to 28.3 on a 0–
100 scale. Absolute change scores for the ﬁrst follow-up
period generally were larger (range 0.4–28.3) than for the
second period (range –2.8–14.2).
The effect sizes for the generic FHS questionnaires
ranged from small to moderate (0.29–0.60). For the generic
TAIQOL subscales however, the effect sizes were lower,
ranging from almost zero for the subscales ‘Appetite’ (0,0),
‘Problem behaviour’ (0.02) and ‘Positive mood’ (0.06) to
small for ‘Sleeping’(0.37) and ‘Liveliness’ (0.22). Effect
sizes for the disease-speciﬁc questionnaires were moderate
to large (0.55–0.95). For the questionnaires the ES were
quite similar for the ﬁrst (0–7 months) and second intervals
(7–14 months), whereas for the second interval absolute
change scores were smaller.
The TAIQOL was excluded from further analyses on the
interpretation of change, due to its poor sensitivity to
change.
Interpretation of change—distribution-based methods
Minimally clinical important differences (MCIDs) calcu-
lated with distribution-based methods are presented in
Table 9. During the ﬁrst interval, ES-MCIDs using an ef-
fect size of 0.3 as benchmark were somewhat smaller for
generic questionnaires, ranging from 5.0 to 7.4 on a 0–100
scale, than those for disease-speciﬁc questionnaires ranging
from 6.1 to 9.4. During the second interval, however, ES-
MCIDs for generic and disease-speciﬁc questionnaires
Table 6 Construct validity—‘correlations* between questionnaire
scores and frequency of physician visits for URTI** and of AOM**
episodes’
Frequency of physician
visits for URTI
Frequency of AOM
episodes***
Generic
RAND –0.48 –0.31
FSQ generic –0.20 –0.07
#
FSQ speciﬁc –0.27 –0.12
##
Disease-speciﬁc
OM-6 –0.32 –0.41
NRS child –0.41 –0.49
FFQ –0.29 –0.39
NRS caregiver –0.41 –0.40
* Spearmans’rho correlation coefﬁcients were calculated
** URTI: upper respiratory tract infection; AOM: acute otitis media
*** All correlations P < 0.001, except for
# (P = 0.16) and
## (P = 0.02)
Table 7 Discriminant validity: scores of children with 2–3 vs. 4 or
more AOM episodes in the preceding year*
2–3 AOM
episodes
‡4 AOM
episodes
Mann–Whitney
P-value
Generic
RAND 21.1 19.6 0.004
FSQ generic 76.5 72.2 0.002
FSQ speciﬁc 83.9 78.4 0.001
TAIQOL
Sleeping 66.2 60.7 0.10
Appetite 74.7 73.2 0.44
Liveliness 93.2 91.3 0.81
Positive mood 92.0 92.5 0.97
Problem
behaviour
64.8 60.9 0.24
Communication 83.8 84.5 0.69
Disease-speciﬁc
OM-6 18.9 17.0 <0.001
NRS child 5.2 5.4 0.48
FFQ 84.9 78.5 <0.001
NRS caregiver 6.6 6.2 0.22
Calculated by Mann–Whitney test
* 2–3 episodes means moderate and >4 episodes means serious AOM
1364 Qual Life Res (2007) 16:1357–1373
123were comparable (range 4.0–6.7), indicating that for both
types of questionnaires similar change scores are needed in
order to be clinically relevant.
Except for the NRS Child and NRS Caregiver, the SEM-
MCIDs were quite comparable with the ES-MCIDs for
both generic and disease-speciﬁc questionnaires. Assuming
that the estimated MCIDs using either an effect size of 0.3
or a one-SEM as benchmark are correct, our results suggest
that the range for the distribution-based MCID for generic
as well as disease-speciﬁc questionnaires corresponds with
a change of 3 - 9 points on a 0–100 scale (see Table 9).
Interpretation of change—anchor-based methods
Changes in AOM frequency (AOM incidence per child per
year) were compared to the magnitude of change scores on
the FHS and HRQoL questionnaires. A small change of 2
AOM episodes, which is considered a MCID, in AOM
frequency corresponded with 3–10 points change on a
0–100 scale for the generic questionnaires (Graph 1a), and
with 5–15 points change for disease-speciﬁc question-
naires, except for the NRS Child during the 0–7 months
interval with 29 points change.
Likewise, a small improvement in AOM severity cor-
responded with change scores ranging from 2–10 points on
a 0–100 scale for the generic questionnaires and with
change scores from 4–8 points for the disease-speciﬁc
questionnaires, except again for the NRS Child with 16 and
17 points change (Graph 1b).
Change scores corresponding with moderate to large
changes in AOM frequency and severity are also pre-
sented in Graph 1a, b. Comparing small change with
moderate to large change shows that, overall, the larger
the change in AOM severity or frequency, the larger the
magnitude of the change score on the questionnaires.
However, this trend was not true for the FSQ Generic
and the disease-speciﬁc NRS Child (e.g., a small change
in AOM severity equalized a change score of 17 on the
NRS Child, whereas a moderate-large change equalized a
change score of 13).
Comparison of anchor- and distribution-based methods
Comparing the results of the anchor-based methods with
those of the distribution-based methods (Graph 2) showed
that generic questionnaires (RAND, FSQ Generic, and FSQ
Speciﬁc), disease-speciﬁc questionnaires (OM-6 and FFQ)
and the NRS Caregiver yielded quite similar estimates of
the MCID for both methods (3–9 points on a 0–100 scale
for distribution and 2–15 points for anchor-based methods)
Table 8 Sensitivity to change: mean change-scores* and effect sizes** for changed subjects
Mean change-score Effect size—GRS
0–7 months
# 7–14 months 0–7 months 7–14 months
n = 270*** P-value n = 126**** P-value n = 270*** n = 126****
Generic
RAND 10.2 <0.001 7.7 <0.001 0.60 0.54
FSQ Generic 7.0 <0.001 4.9 0.001 0.37 0.29
FSQ speciﬁc 9.1 <0.001 6.0 <0.001 0.37 0.32
TAIQOL
Sleeping 9.9 <0.001 7.1 0.03 0.37 0.36
Appetite 6.8 0.001 0.0 1.0 0.28 0.00
Problem behaviour 0.4 0.80 –2.8 0.33 0.02 0.13
Positive mood 1.5 0.30 3.9 0.11 0.06 0.25
Liveliness 2.3 0.19 1.6 0.51 0.22 0.11
Communication 2.9 0.12 1.7 0.32 0.16 0.11
Disease-speciﬁc
OM-6 16.6 <0.001 11.5 <0.001 0.60 0.73
NRS child 28.3 <0.001 14.2 <0.001 0.91 0.64
FFQ 13.6 <0.001 8.0 <0.001 0.55 0.60
NRS caregiver 19.2 0.003 9.1 0.003 0.95 0.57
* calculated with paired t-test
**calculated with Guyatt’s responsiveness statistic (GRS)
*** n = 114 for TAIQOL subscales and NRS Caregiver;
# follow-up interval
**** n = 51 for TAIQOL subscales and NRS Caregiver
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0–7 months interval, 2–8 points for 7–14 months interval).
Averaging these distribution-based and anchor-based esti-
mates of MCID yields a point-estimate MCID for generic
questionnaires of 6.0 (range 2–10) and for disease-speciﬁc
questionnaires of 7.3 (range 3–15) on a 0–100 scale
(excluding the NRS Child, as it had much larger estimates
for the MCID).
Discussion
In this study, the reliability and validity of generic as well
as disease-speciﬁc FHS and HRQoL questionnaires have
been assessed in the setting of a RCT concerning children
with recurrent AOM. Most generic (RAND, FSQ-Generic
and FSQ-Speciﬁc) and disease-speciﬁc (OM-6 and FFQ)
questionnaires showed similar, good to excellent reliability
and adequate construct and discriminant validity. Construct
validity was poor for the numerical rating scales (NRS
Child and NRS Caregiver), and discriminant validity was
low to moderate for both NRS and the subscales of the
TAIQOL considered to be otitis media-related (Tables 4, 5,
6 and 7).
Generic as well as disease-speciﬁc questionnaires
proved to be sensitive to change in the incidence of
AOM (Table 8). The effect sizes were found to be
ranging from small to moderate for both generic and
disease-speciﬁc questionnaires (Table 8). The MCIDs for
generic and disease-speciﬁc questionnaires were quite
similar in terms of responsiveness (Table 9 and Figure 1
& 2). However, most otitis media-related subscales of the
TAIQOL, the only true HRQoL questionnaire, proved
insensitive to change.
Reliability and validity
Results on internal consistency and test–retest reliability of
the RAND, FSQ Generic, FSQ Speciﬁc, TAIQOL and OM-
6 found in this study, were comparable with those of pre-
vious studies using these questionnaires [14, 41, 42, 51,
52]. The consistency of results across different paediatric
populations supports the reliability of these questionnaires.
Similar to the poor discriminant validity in this study of the
otitis media-related TAIQOL subscales, Fekkes et al. [51]
found the TAIQOL subscales ‘Problem behaviour’, ‘Posi-
tive mood’, and ‘Liveliness’ discriminated neither between
healthy and preterm children nor between healthy and
chronically ill children. The ability of the RAND, FSQ
Generic and FSQ Speciﬁc to discriminate between children
who differed in AOM frequency, on the other hand, sup-
ported their discriminant validity previously found in
children with asthma and healthy children [41, 42]. How-
ever, the heterogeneity of methods used limits the com-
parability of results regarding validity of this study with
those from previous studies.
The FFQ and NRS Caregiver are newly composed
questionnaires to assess the inﬂuence of recurrent AOM on
the caregiver and family. The FFQ demonstrated excellent
reliability and validity, meeting the minimal required
reliability coefﬁcients of 0.90 for individual assessment
[65, 87]. The strong correlation with the OM-6 supports its
complementary usefulness in FHS and HRQoL assessment
in children with rAOM. Results of the NRS Caregiver,
however, were similarly poor as those observed for the
NRS Child, which needs further exploration. Their global,
single-item assessment of HRQoL may be too crude to
reﬂect subtle differences in HRQoL [88, 89]. On the other
hand, comments of the caregivers indicated that some of
Table 9 Responsiveness—distribution-based indices for minimally clinical important difference (MCID) using 0.3 Effect Size (ES) and one
standard error of measurement (SEM)
ES—MCID* SEM—MCID**
0–7 months
# 7–14 months 0–7 months 7–14 months
Generic
RAND 5.0 4.3 5.3 4.5
FSQ generic 5.7 5.1 5.4 4.8
FSQ speciﬁc 7.4 5.6 7.8 5.9
Disease-speciﬁc
OM-6 8.3 4.7 8.8 5.0
NRS child 9.4 6.7 12.5 8.9
FFQ 7.4 4.0 6.1 3.3
NRS caregiver 6.1 4.8 8.3 6.6
* MCID using 0.3 effect size as benchmark;
# follow-up interval
** MCID using one-SEM as benchmark
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Graph 1 Responsiveness—change-scores per questionnaire corresponding with an anchor-based responsiveness index: (a) AOM frequency;
(b) AOM severity (OM-FSQ score)
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123them may have misunderstood the NRS test-instructions.
This is supported by the fact that improvement of construct
validity occurred during follow-up assessments, presum-
ably due to learning effects after reading the instructions a
second time.
Responsiveness
So far, little attention has been given to the responsiveness
of the questionnaires used in our study. Only Rosenfeld
et al. [55] assessed effect sizes for the OM-6 (using a
standardized response mean) that were much larger (1.1–
1.7) than the ones found in this study. This may be ex-
plained by the use of different identiﬁers of change. Ro-
senfeld et al. [55] used an intervention with expected
clinical effectiveness, for which proxies were not blinded,
as indicator of change. Since pneumococcal vaccination
proved to be clinically ineffective [74], treatment could not
be used as an external criterion for change. Instead, a
change of 2 or more AOM episodes per year was used as
criterion to identify changed subjects. In addition, social
desirability and expectancy bias may have inﬂuenced the
outcome of the study of Rosenfeld et al. [55]
Although clinical criteria such as change in the inci-
dence of AOM episodes have been suggested as adequate
alternative criteria to identify change [34], the choice for
any external criterion for change remains somewhat arbi-
trary. It is a surrogate measure that often only reﬂects one
aspect of the QoL construct. The poor responsiveness of
the TAIQOL subscales ‘Behavioural problems’, ‘Positive
mood’ and ‘Liveliness’, for example, may indicate that our
clinical indicator is less suitable as external criterion for
change in emotional and behavioural functioning. How-
ever, considering the overall poor responsiveness of the
twelve TAIQOL subscales (results not shown), it seems
more obvious that poor responsiveness in itself mainly
applies for these three subscales as well.
Several studies have supported the empirically found
link between one SEM and the MCID for HRQoL ques-
tionnaires [75, 81, 85, 86]. In this study the MCIDS based
on the value of one-SEM largely corresponded with a
MCID that was estimated using 0.3 ES as a benchmark,
which is in further support of the one-SEM as an indicator
of MCID (Table 9). However, it should be realized that the
SEM as well as the ES are both only statistical indicators,
which relate change to random (error) variance. Interest-
ingly, the anchor-based methods yielded similar estimates
for the MCIDs (Graphs 1a, b, 2), which is in agreement
with recent observations that one-SEM equals anchor-
based MCID in patients with moderately severe illness
0
5
10
15
20
25
30
RAND
MCID
FSQ Generic
MCID
FSQ Specific
MCID
OM-6
MCID
NRS Child
MCID
FFQ
MCID
NRS caregiver
MCID
0-7 mo   7-14 mo   0-7 mo  7-14 mo  0-7 mo   7-14 mo  0-7 mo   7-14 mo Mean
ES-MCID              SEM-MCID         AOM frequency      AOM severity
Change 
score
(MCID)
Graph 2 Minimally clinical important difference (MCID) per questionnaire according to distribution-based (ES-MCID and SEM-MCID) and
anchor-based (AOM frequency and AOM severity) methods
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as two evaluation periods, we have not only been able to
demonstrate consistency in responsiveness but also to give
ranges for minimally clinical important changes instead of
point-estimates. As there is no ‘golden standard’ for the
assessment of responsiveness in FHS and HRQoL mea-
surement, a range of scores gives a more realistic reﬂection
of responsiveness than a point-estimate. Point estimates
can be misapplied by users who are either unaware of the
limited precision of data used for estimating the MCID or
who are unaware of the intrinsic limitations of dichoto-
mising what is actually a continuum.
Generic versus disease-speciﬁc questionnaires
Although generic questionnaires are generally expected to
be less sensitive to differences in FHS or HRQoL than
disease-speciﬁc questionnaires [19, 37, 91, 92], in this
study most disease-speciﬁc questionnaires performed only
marginally better than the generic questionnaires on the
discriminant validity test. Likewise, the responsiveness of
generic questionnaires, and their usefulness as measures of
outcome in randomized trials has been questioned [21].
Although in some studies generic measures indeed were
found to be less responsive to treatment effects than spe-
ciﬁc measures [93–96], other studies did ﬁnd comparable
responsiveness [97–99]. In this study, only the smaller
effect sizes for the FSQ Generic and FSQ Speciﬁc may
indicate that sensitivity to responsiveness of generic
questionnaires is somewhat poorer than that of disease-
speciﬁc questionnaires. Possibly, this higher sensitivity at
the start of the study reﬂects the higher incidence of
symptoms and functional limitations that are speciﬁc to
AOM, whereas during the study AOM incidence decreases
and consequently AOM symptoms become less prominent
compared to other health problems. Overall, the generic
questionnaires appeared to be as sensitive to clinical
change as disease-speciﬁc questionnaires, except for the
TAIQOL.
For the FSQ Generic and FSQ Speciﬁc, but not for the
RAND which assesses general health perceptions, sensi-
tivity to differences and change in FHS could be ex-
plained by their content, as they include many physical
and emotional behaviour items that may be affected by
rAOM. The more relevant a questionnaire is to a partic-
ular condition, the more sensitive it is likely to be. The
sensitivity of the RAND, assessing general health and
resistance to illness, may indicate that it meets the per-
ceptions of the caregivers of children with rAOM in
thinking that their overall health is worse compared with
other children. It also may reﬂect the signiﬁcant co-
morbidity like chronic airway problems and atopic
symptoms in the study population (Table 3).
The reasons for the poor performance of the TAIQOL
with regard to both discriminant validity and sensitivity to
change are not obvious. Possibly the subscale scores rep-
resent each an aspect of HRQoL that is too limited to be
sensitive to differences or change. Combining the subscales
to more comprehensive constructs may then improve sen-
sitivity. In addition, each item of the TAIQOL consists of
two questions; a question about FHS is followed by the
request to rate the child’s well-being in relation to this
health status. Response shift bias may have modiﬁed the
caregivers’ expectations about how their child feels in line
with the child’s changing health, that is caregivers may rate
their child’s well-being as better than it actually is as they
adapt to the situation. Studies on factors that may inﬂuence
sensitivity to change or responsiveness besides the type of
questionnaire (generic versus disease-speciﬁc), such as
questionnaire structure and content, disease severity, co-
morbidity and other population characteristics, are needed.
Bias and generalisibility
There are several issues that need to be considered when
interpreting the current results. First, frequency of AOM
episodes at enrolment was based on proxy report, whereas
during the trial only physician-diagnosed episodes were
counted. The number of AOM episodes in the year prior to
inclusion is likely to be overestimated by proxies [100],
resulting in the underestimation of HRQoL change scores
because they may have evaluated the situation as worse
than it objectively was in the ﬁrst place. However, if such a
recall-bias regarding AOM frequency was in fact present, it
may also have inﬂuenced caregivers’ reﬂection on sub-
jective measures such as FHS and HRQoL, which results in
realistic or even overestimated change scores. However,
estimating responsiveness for the interval of 7–14 months,
in which AOM frequency was not affected by recall bias
since al episodes were physician diagnosed, yielded similar
results. This indicates that recall bias appears not to have
inﬂuenced responsiveness substantially.
Secondly, in assessing test–retest reliability, two dif-
ferent modes of questionnaire administration were used:
completion at the clinic versus home completion. The
possible intention to give more socially desirable answers
at the clinic as well as other effects such as being more
distracted when ﬁlling in the questionnaires at home, may
have caused differences in questionnaire scores between
the ﬁrst (test) and second (retest) assessment. Although this
impact may be larger for single item questionnaires such as
the NRSs compared to multiple item questionnaires, and
might explain their somewhat smaller ICCs, the impact on
the ICCs appears to be small.
Thirdly, during the trial, 8 children (4.2%) in the
pneumococcal vaccine group and 13 (6.7%) in the control
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123vaccine group were lost to follow-up. One child switched
from the control to the pneumococcal vaccine group. It is
unlikely that these small numbers of dropouts and cross-
overs inﬂuenced the trial results.
Furthermore, indices of validity and reliability are not
ﬁxed characteristics of FHS and HRQoL questionnaires but
are inﬂuenced by the study design, intervention, and study
population in particular. Our study population had signiﬁ-
cantly severe ear disease with frequent episodes and was
older than the average child with AOM. Assessment of
reliability and validity of the questionnaires in populations
with less severe disease may present more ceiling effects
and lack of discriminant validity. Therefore, the results of
this study should only be generalized to paediatric popu-
lations with moderately to seriously severe recurrent acute
ear-infections at an older age (approximately 14–
54 months).
Finally, of all questionnaires in this study, only the FFQ
demonstrated a reliability that meets the minimal required
reliability coefﬁcients for individual assessment of
HRQoL. Although some authors suggest to use FHS and
HRQoL questionnaires for individual assessment in clinical
practice as well [31], we do not support this approach. It is
suggested that routine use of these questionnaires would
facilitate detection and discussion of psychological issues
and help guide decisions regarding, for example, referral.
However, considering the complexity and many pitfalls of
reproducibility and responsiveness assessment, individual
use of HRQoL and FHS questionnaires as part of the fol-
low-up of individuals is not reliable nor valid.
Recommendations for clinical use
In conclusion, generic (RAND, FSQ Generic and FSQ
Speciﬁc) as well as disease-speciﬁc (OM-6, FFQ, and, to a
lesser extent, NRS Caregiver) questionnaires demonstrated
similar and high reliability and adequate construct and
discriminant validity as well as responsiveness to justify
use in clinical studies of children with rAOM. However,
NRS as used in this study may be less adequate for
assessment of HRQoL in this population. The TAIQOL,
the only true generic HRQoL questionnaire, unfortunately
showed a poor discriminant validity and sensitivity to
change, needing extensive revision before further use in
clinical outcome studies in children with otitis media.
Using both a generic questionnaire (RAND or FSQ) and
the OM-6 in clinical studies regarding FHS in children with
rAOM is recommended, as it would combine the merits of
both generalisability and sensitivity in outcome assessment
and facilitate head-to-head comparisons of their perfor-
mance in various paediatric populations with OM.
More studies are needed assessing responsiveness of
paediatric QoL questionnaires by multiple, distribution as
well as anchor-based, methods to increase our appreciation
of minimal clinically important changes in various paedi-
atric conditions. Further studies on factors such as ques-
tionnaire structure and content, disease severity, co-
morbidity and other population characteristics that may
inﬂuence sensitivity to change or responsiveness besides
the type of questionnaire (generic versus disease-speciﬁc)
may increase our appreciation of the complex dynamics in
HRQoL and FHS assessment.
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